Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial : Early Surrogate Endpoints Revisited
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cancers. 14
- Event
-
Veröffentlichung
- (where)
-
Leipzig
- (who)
-
Universitätsbibliothek Leipzig
- (when)
-
2023
- URN
-
urn:nbn:de:bsz:15-qucosa2-877939
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:48 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Diefenhardt, Markus
- Schlenska-Lange, Anke
- Kuhnt, Thomas
- Kirste, Simon
- Piso, Pompiliu Ioan
- Bechstein, Wolf Otto
- Hildebrandt, Guido
- Ghadimi, Michael
- Hofheinz, Ralf-Dieter
- Rödel, Claus
- Fokas, Emmanouil
- Universitätsbibliothek Leipzig
Time of origin
- 2023
Other Objects (12)
Total neoadjuvant therapy for rectal cancer in the CAO/ARO/AIO-12 randomized phase 2 trial: early surrogate endpoints revisited
Development and validation of a predictive model for toxicity of neoadjuvant chemoradiotherapy in rectal cancer in the CAO/ARO/AIO-04 phase III trial
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
Computertomography-based prediction of complete response following neoadjuvant chemoradiotherapy of locally advanced rectal cancer
Prognosis of rectal cancer patients improves with downstaging by intensified neoadjuvant radiochemotherapy - a matched pair analysis
Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- and diffusion-weighted MRI
ARO
Cao Cao und Yang Xiu
Bukarest: Brand des ARO (Sala ARO)
Bukarest: Brand des ARO (Sala ARO)
Total neoadjuvant therapy for rectal cancer in the CAO/ARO/AIO-12 randomized phase 2 trial: early surrogate endpoints revisited
Development and validation of a predictive model for toxicity of neoadjuvant chemoradiotherapy in rectal cancer in the CAO/ARO/AIO-04 phase III trial
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
Computertomography-based prediction of complete response following neoadjuvant chemoradiotherapy of locally advanced rectal cancer
Prognosis of rectal cancer patients improves with downstaging by intensified neoadjuvant radiochemotherapy - a matched pair analysis
Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- and diffusion-weighted MRI
ARO
Cao Cao und Yang Xiu
Bukarest: Brand des ARO (Sala ARO)
Bukarest: Brand des ARO (Sala ARO)
Total neoadjuvant therapy for rectal cancer in the CAO/ARO/AIO-12 randomized phase 2 trial: early surrogate endpoints revisited
Development and validation of a predictive model for toxicity of neoadjuvant chemoradiotherapy in rectal cancer in the CAO/ARO/AIO-04 phase III trial
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
Computertomography-based prediction of complete response following neoadjuvant chemoradiotherapy of locally advanced rectal cancer
Prognosis of rectal cancer patients improves with downstaging by intensified neoadjuvant radiochemotherapy - a matched pair analysis
Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- and diffusion-weighted MRI
ARO
Cao Cao und Yang Xiu
Bukarest: Brand des ARO (Sala ARO)